Pulike secures new veterinary drug registration for poultry vaccine

Pulike Biological Engineering Co., Ltd. has received a new veterinary drug registration certificate from the Ministry of Agriculture and Rural Affairs for its bivalent live vaccine targeting Newcastle disease and infectious bronchitis in chickens.

The vaccine is classified as a Class III new veterinary drug and provides immunity within 7 days with a 3-month immune period. It is administered via eye or nasal drops for chickens aged 2 days or older.

This development is expected to enhance Pulike's competitiveness in the poultry vaccine market.